Surgery Partners (SGRY) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
3.1B
Gross Profit
745.6M
23.94%
Operating Income
454.3M
14.59%
Net Income
12.5M
0.40%
EPS (Diluted)
-$1.33
Balance Sheet Metrics
Total Assets
7.9B
Total Liabilities
4.3B
Shareholders Equity
3.6B
Debt to Equity
1.17
Cash Flow Metrics
Operating Cash Flow
256.4M
Free Cash Flow
209.7M
Revenue & Profitability Trend
Surgery Partners Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.1B | 2.7B | 2.5B | 2.2B | 1.9B |
| Cost of Goods Sold | 2.4B | 2.1B | 2.0B | 1.7B | 1.5B |
| Gross Profit | 745.6M | 647.5M | 574.9M | 491.4M | 379.8M |
| Operating Expenses | 138.7M | 119.8M | 99.8M | 66.1M | 50.9M |
| Operating Income | 454.3M | 409.6M | 360.3M | 326.5M | 234.1M |
| Pre-tax Income | 147.1M | 135.0M | 110.3M | 81.2M | -18.8M |
| Income Tax | 134.6M | 300.0K | 23.3M | 10.5M | -20.1M |
| Net Income | 12.5M | 135.3M | 87.0M | 70.7M | 1.3M |
| EPS (Diluted) | -$1.33 | -$0.09 | -$0.59 | -$1.12 | -$3.19 |
Income Statement Trend
Surgery Partners Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.1B | 895.0M | 921.0M | 946.1M | 801.5M |
| Non-Current Assets | 6.8B | 6.0B | 5.8B | 5.2B | 4.6B |
| Total Assets | 7.9B | 6.9B | 6.7B | 6.1B | 5.4B |
| Liabilities | |||||
| Current Liabilities | 624.4M | 523.0M | 493.4M | 536.8M | 556.8M |
| Non-Current Liabilities | 3.6B | 3.0B | 2.9B | 3.3B | 3.2B |
| Total Liabilities | 4.3B | 3.5B | 3.4B | 3.8B | 3.8B |
| Equity | |||||
| Total Shareholders Equity | 3.6B | 3.4B | 3.3B | 2.3B | 1.6B |
Balance Sheet Composition
Surgery Partners Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 12.5M | 135.3M | 87.0M | 70.7M | 1.3M |
| Operating Cash Flow | 256.4M | 266.1M | 134.6M | 75.6M | 207.2M |
| Investing Activities | |||||
| Capital Expenditures | -87.8M | -63.0M | -67.7M | -51.6M | 15.6M |
| Investing Cash Flow | -488.5M | -225.6M | -307.9M | -331.7M | -88.4M |
| Financing Activities | |||||
| Dividends Paid | - | 0 | 0 | -5.1M | 0 |
| Financing Cash Flow | 262.0M | -155.2M | 42.1M | 316.3M | 66.7M |
| Free Cash Flow | 209.7M | 205.0M | 78.2M | 29.5M | 204.0M |
Cash Flow Trend
Surgery Partners Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
2,956.00
Forward P/E
17.49
Price to Book
1.61
Price to Sales
0.89
PEG Ratio
17.49
Profitability Ratios
Profit Margin
-6.09%
Operating Margin
11.55%
Return on Equity
-0.35%
Return on Assets
3.97%
Financial Health
Current Ratio
1.89
Debt to Equity
108.05
Beta
1.94
Per Share Data
EPS (TTM)
-$1.53
Book Value per Share
$13.67
Revenue per Share
$25.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| sgry | 2.8B | 2,956.00 | 1.61 | -0.35% | -6.09% | 108.05 |
| HCA Healthcare | 87.0B | 16.05 | -201.13 | 1,605.77% | 8.07% | -106.02 |
| Tenet Healthcare | 16.3B | 11.27 | 3.90 | 28.82% | 7.09% | 152.20 |
| Ensign Group | 8.0B | 26.20 | 4.12 | 17.64% | 7.00% | 104.09 |
| Chemed | 6.6B | 22.13 | 5.60 | 26.11% | 12.40% | 12.28 |
| Option Care Health | 5.0B | 24.54 | 3.72 | 15.38% | 4.12% | 90.53 |
Financial data is updated regularly. All figures are in the company's reporting currency.